Mounjaro, a weekly injectable drug by Eli Lilly for treating type 2 diabetes and obesity, competes with another high-profile drug, Ozempic (manufactured by Danish drugmaker, Novo Nordisk)
Related Posts
Lost Syrian Weapons Supply Route After Fall Of Bashar Al-Assad Regime: Hezbollah Chief Qassem
Hezbollah head Naim Qassem said on Saturday that the Lebanese armed group had lost its supply route through Syria, in his first comments since the […]
Leaked Documents Reveal PFI’s Financial Backing Of SDPI | Exclusive
The leaked minutes of meetings and handwritten notes reveal that PFI not only authorised SDPI to raise funds from Gulf nations but also financed its […]
Shashi Tharoor Praises Modi Govt’s Covid Vaccine Diplomacy, Calling It A ‘Powerful Example’ | News18
Shashi Tharoor praises Modi govt’s vaccine initiative. He writes “India’s vaccine diplomacy during the Covid pandemic stands out from amid the horrors of that time […]